Physician profile
Nicholas Monaco
NPI 1962973750
$710.93
in general payments reported to CMS, 2019-2025
9 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $166 · 2023: $71.88 · 2024: $107 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.25 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $149.10 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $147.68 | 2023-2025 | Camzyos |
| Medtronic, INC. | $147.04 | 2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $102.21 | 2023-2025 | Farxiga, Lokelma, Brilinta |
| Scpharmaceuticals INC. | $77.33 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.60 | 2025 | Lifevest |
| Edwards Lifesciences Corporation | $19.56 | 2025 | |
| Boston Scientific Corporation | $18.83 | 2024 | Watchman |
| Janssen Pharmaceuticals, INC | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Monaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.